Chemokines as Therapeutic Targets in Non-Small Cell Lung Cancer: Update
Journal:
Medicinal Chemistry Reviews - Online (Discontinued)
Volume:
1
Page:
253-256
Author(s):
D. A. Arenberg
Intriguing Classes of Acridine Derivatives as DNA-binding Antitumour Agents: From Pyrimido[5,6,1-de]acridines to Bis(acridine-4-carboxamides)
Journal:
Medicinal Chemistry Reviews - Online (Discontinued)
Volume:
1
Page:
267-290
Author(s):
Ippolito Antonini
Induction of Tumour Cell Senescence: A New Strategy in Anticancer Treatment
Journal:
Medicinal Chemistry Reviews - Online (Discontinued)
Volume:
1
Page:
369-379
Author(s):
Xianghong Wang and Yong-Chuan Wong
Photodynamic Therapy using Carbohydrate Conjugated Porphyrins
Journal:
Drug Design Reviews - Online (Discontinued)
Volume:
1
Page:
215-234
Author(s):
X. Chen and C. M. Drain
Effect of Prostaglandins on the Regulation of Tumor Growth
Journal:
Current Medicinal Chemistry - Anti-Cancer Agents
Volume:
4
Page:
379-387
Author(s):
Shunji Ishihara, M A.K. Rumi, Toshihiko Okuyama and Yoshikazu Kinoshita
Cytochrome P450 Gene Polymorphism and Cancer
Journal:
Current Drug Metabolism
Volume:
5
Page:
211-224
Author(s):
Jose A.G. Agundez
Cytochrome P450 Regulation and Drug Biotransformation During Inflammation and Infection
Journal:
Current Drug Metabolism
Volume:
5
Page:
235-243
Author(s):
Kenneth W. Renton
Targeting MAPK Signalling: Prometheus Fire or Pandoras Box?
Journal:
Current Pharmaceutical Design
Volume:
10
Page:
1885-1905
Author(s):
Simone Boldt and Walter Kolch
MEK Inhibitors: A Therapeutic Approach to Targeting the Ras-MAP Kinase Pathway in Tumors
Journal:
Current Pharmaceutical Design
Volume:
10
Page:
1907-1914
Author(s):
Judith S. Sebolt-Leopold
The Role of Protein Kinase C-alpha (PKC-α) in Cancer and its Modulation by the Novel PKC-α-Specific Inhibitor Aprinocarsen
Journal:
Current Pharmaceutical Design
Volume:
10
Page:
1923-1936
Author(s):
A- R. Hanauske, Karen Sundell and Michael Lahn